FLKS FLKS
Set alert
Day range unavailable
52-week range unavailable
News
-
7 years ago benzinga.com
Mid-Afternoon Market Update: Crude Oil Down 1.5%; C&J Energy Services Shares Spike Higher
Mid-Afternoon Market Update: Crude Oil Down 1.5%; C&J Energy Services Shares Spike Higher
-
7 years ago benzinga.com
44 Stocks Moving In Monday's Mid-Day Session
44 Stocks Moving In Monday's Mid-Day Session
-
7 years ago benzinga.com
Mid-Day Market Update: Sotheby's Jumps On Acquisition News; Flex Pharma Shares Slide
Mid-Day Market Update: Sotheby's Jumps On Acquisition News; Flex Pharma Shares Slide
-
7 years ago benzinga.com
Mid-Morning Market Update: Markets Open Higher; Pfizer To Acquire Array BioPharma For $48/Share
Mid-Morning Market Update: Markets Open Higher; Pfizer To Acquire Array BioPharma For $48/Share
7 years ago businesswire.com
Flex Pharma and Salarius Pharmaceuticals Announce Merger Agreement to Accelerate Clinical Development of Novel Epigenetic Therapy for Cancer
BOSTON & HOUSTON--(BUSINESS WIRE)--Flex Pharma, Inc. (NASDAQ: FLKS), and Salarius Pharmaceuticals, LLC, a clinical-stage oncology company targeting the epigenetic causes of cancers, today announced…
-
7 years ago benzinga.com
Stocks Which Set New 52-Week Low Yesterday, Tues., Dec. 20, 2018
Stocks Which Set New 52-Week Low Yesterday, Tues., Dec. 20, 2018
-
7 years ago benzinga.com
Stocks Which Set New 52-Week Low Yesterday, Tues., Dec. 18, 2018
Stocks Which Set New 52-Week Low Yesterday, Tues., Dec. 18, 2018
-
7 years ago benzinga.com
Stocks Which Set New 52-Week Low Yesterday, Wed., Nov. 28, 2018
Stocks Which Set New 52-Week Low Yesterday, Wed., Nov. 28, 2018
-
7 years ago benzinga.com
42 Stocks Moving In Monday's Mid-Day Session
42 Stocks Moving In Monday's Mid-Day Session
-
8 years ago benzinga.com
Stocks Which Set New 52-Week Low Yesterday, September 20th
Stocks Which Set New 52-Week Low Yesterday, September 20th
-
8 years ago benzinga.com
Stocks Which Set New 52-Week Low Friday, September 7th
Stocks Which Set New 52-Week Low Friday, September 7th
-
8 years ago benzinga.com
Stocks Which Set New 52-Week Low Yesterday, September 5th
Stocks Which Set New 52-Week Low Yesterday, September 5th
-
8 years ago benzinga.com
Stocks Which Set New 52-Week Low Friday, August 24th
Stocks Which Set New 52-Week Low Friday, August 24th
-
8 years ago benzinga.com
Stocks Which Set New 52-Week Low Yesterday, August 15th
Stocks Which Set New 52-Week Low Yesterday, August 15th
-
8 years ago benzinga.com
Stocks Which Set New 52-Week Low Yesterday, August 6th
Stocks Which Set New 52-Week Low Yesterday, August 6th
-
8 years ago benzinga.com
Stocks Which Set New 52-Week Lows Friday, August 3rd
Stocks Which Set New 52-Week Lows Friday, August 3rd
-
8 years ago benzinga.com
Stocks Which Set New 52-Week Low Yesterday, August 2nd
Stocks Which Set New 52-Week Low Yesterday, August 2nd
8 years ago businesswire.com
Flex Pharma to Report First Quarter 2018 Financial Results on May 2, 2018
BOSTON--(BUSINESS WIRE)--Flex Pharma, Inc. (NASDAQ: FLKS), a clinical-stage biotechnology company that is developing innovative and proprietary treatments for cramps and spasticity associated with…
8 years ago businesswire.com
Flex Pharma Reports Positive Topline Data from Exploratory Phase 2 Trial of FLX-787 in Multiple Sclerosis
BOSTON--(BUSINESS WIRE)--Flex Pharma, Inc. (NASDAQ:FLKS), a clinical-stage biotechnology company that is developing innovative and proprietary treatments for cramps, spasms and spasticity associated…
8 years ago businesswire.com
Flex Pharma to Report Fourth Quarter and Full Year 2017 Results on March 7, 2018
BOSTON--(BUSINESS WIRE)--Click to Tweet Flex Pharma, Inc. (NASDAQ: FLKS), a clinical-stage biotechnology company that is developing innovative and proprietary treatments for cramps and spasticity…
9 years ago businesswire.com
Flex Pharma to Report Third Quarter 2017 Results on November 6, 2017
BOSTON--(BUSINESS WIRE)--Click to Tweet this News Flex Pharma, Inc. (NASDAQ: FLKS), a clinical-stage biotechnology company that is developing innovative and proprietary treatments for cramps and…
9 years ago businesswire.com
Flex Pharma to Report Second Quarter 2017 Results on August 2, 2017
BOSTON--(BUSINESS WIRE)--Click to Tweet Flex Pharma, Inc. (NASDAQ: FLKS), a clinical-stage biotechnology company that is developing innovative and proprietary treatments for cramps and spasticity…
9 years ago businesswire.com
Flex Pharma Reports First Quarter 2017 Financial Results
BOSTON--(BUSINESS WIRE)--Click to Tweet this News Flex Pharma, Inc. (NASDAQ: FLKS), a biotechnology company that is developing innovative and proprietary treatments for cramps and spasms associated…
9 years ago businesswire.com
Flex Pharma to Report Fourth Quarter and Full Year 2016 Results on March 8, 2017
BOSTON--(BUSINESS WIRE)--Click to Tweet Flex Pharma, Inc. (NASDAQ: FLKS), a biotechnology company that is developing innovative and proprietary treatments for cramps and spasms associated with the…
10 years ago businesswire.com
Flex Pharma to Report Third Quarter 2016 Results on November 2, 2016
BOSTON--(BUSINESS WIRE)--Click to Tweet Flex Pharma, Inc. (NASDAQ: FLKS), a biotechnology company developing innovative and proprietary treatments for nocturnal leg cramps (NLC), cramps and spasms…
10 years ago businesswire.com
Flex Pharma Provides FLX-787 Nocturnal Leg Cramp Regulatory and Clinical Update
BOSTON--(BUSINESS WIRE)--Click to Tweet Flex Pharma, Inc. (NASDAQ: FLKS) today provided a nocturnal leg cramp (NLC) regulatory and clinical update for FLX-787, a topically-acting, selective transient…
10 years ago businesswire.com
Flex Pharma to Report Second Quarter 2016 Results on August 3, 2016
BOSTON--(BUSINESS WIRE)--Click to Tweet Flex Pharma, Inc. (NASDAQ: FLKS), a biotechnology company developing innovative and proprietary treatments for nocturnal leg cramps (NLC), cramps and spasms…
10 years ago businesswire.com
Flex Pharma to Report First Quarter 2016 Results on May 4, 2016
BOSTON--(BUSINESS WIRE)--Click to Tweet Flex Pharma, Inc. (NASDAQ: FLKS), a biotechnology company developing innovative and proprietary treatments for nocturnal leg cramps (NLC), spasms associated…
10 years ago businesswire.com
Flex Pharma to Report Full Year 2015 Results on March 8, 2016
BOSTON--(BUSINESS WIRE)--Click to Tweet Flex Pharma, Inc. (NASDAQ: FLKS), a biotechnology company developing innovative and proprietary treatments for nocturnal leg cramps (NLC), spasms associated…
10 years ago businesswire.com
Flex Pharma Announces Positive Human Efficacy in Nocturnal Leg Cramp Study
BOSTON--(BUSINESS WIRE)--Click to Tweet Flex Pharma, Inc. (NASDAQ: FLKS), a biotechnology company developing innovative and proprietary treatments for nocturnal leg cramps (NLC), spasms associated…
11 years ago businesswire.com
Flex Pharma to Report Third Quarter 2015 Results on November 4, 2015
BOSTON--(BUSINESS WIRE)--Click to Tweet this News Flex Pharma, Inc. (NASDAQ: FLKS), a biotechnology company that is developing innovative and proprietary treatments for exercise-associated muscle…
11 years ago businesswire.com
Flex Pharma to Report Second Quarter 2015 Results on August 5, 2015
BOSTON--(BUSINESS WIRE)--Click to Tweet this News Flex Pharma, Inc. (NASDAQ: FLKS), a biotechnology company that is developing innovative and proprietary treatments for exercise-associated muscle…
11 years ago businesswire.com
Flex Pharma to Report First Quarter 2015 Results on May 6, 2015
BOSTON--(BUSINESS WIRE)--Click to Tweet Flex Pharma, Inc. (NASDAQ: FLKS), a biotechnology company that is developing innovative and proprietary treatments for exercise-associated muscle cramps,…
11 years ago businesswire.com
Flex Pharma to Report Full Year 2014 Results on March 17, 2015
BOSTON--(BUSINESS WIRE)--Flex Pharma, Inc. (NASDAQ:FLKS), a biotechnology company that is developing innovative and proprietary treatments for nocturnal leg cramps and spasms associated with severe…